Considerations for Calculating and Reporting Continuous Glucose Monitoring Wear-Time in Research Settings

Abstract

Graphical Abstract

This is a visual representation of the abstract.

Get full access to this article

View all access options for this article.

References

Martens

, Beck

, Bailey

, et al.; MOBILE Study Group. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA, 2021; 325(22):2262–2272.

Laffel

, Kanapka

, Beck

, et al.; CDE10. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: A randomized clinical trial. JAMA, 2020; 323(23):2388–2396.

Divan

, Greenfield

, Morley

, et al. Perceived burdens and benefits associated with continuous glucose monitor use in type 1 diabetes across the lifespan. J Diabetes Sci Technol, 2022; 16(1):88–96.

Battelino

, Alexander

, Amiel

, et al. Continuous glucose monitoring and metrics for clinical trials: An international consensus statement. Lancet Diabetes Endocrinol, 2023; 11(1):42–57.

American Diabetes Association Professional Practice Committee; 6. Glycemic goals and hypoglycemia: Standards of care in diabetes—2025. Diabetes Care, 2025; 48(Suppl 1):S128–S145; doi: 10.2337/dc25-S006